Melanie A Ruffner Selected Research

Melanie A Ruffner Research Topics

6	Eosinophilic Esophagitis 01/2022 - 08/2017
5	Food Hypersensitivity (Food Allergy) 01/2022 - 11/2016
5	Enterocolitis 01/2022 - 07/2013
4	Inflammation (Inflammations) 01/2022 - 08/2017
4	Eosinophilia 01/2020 - 01/2018
3	Asthma (Bronchial Asthma) 01/2022 - 11/2018
3	Hypersensitivity (Allergy) 11/2018 - 02/2009
2	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2020
2	Experimental Arthritis 07/2010 - 02/2009
1	Asthma and Nasal Polyps 01/2022
1	Esophageal Diseases 01/2022
1	Hyperplasia 01/2022
1	Nasal Polyps (Nasal Polyp) 01/2022
1	Vomiting 01/2022
1	Gastroesophageal Reflux (GERD) 01/2021
1	Allergic Rhinitis 01/2020
1	Eosinophilic enteropathy 07/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Neoplasms (Cancer) 07/2012
1	Hyperglycemia 07/2010
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2010
1	Arthritis (Polyarthritis) 02/2009
1	Rheumatoid Arthritis 02/2009

8	Immunoglobulin E (IgE)IBA 01/2022 - 07/2013
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2013
3	CytokinesIBA 01/2020 - 02/2009
2	Interleukin-4 (Interleukin 4)IBA 01/2022 - 07/2010
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	AllergensIBA 01/2022 - 01/2018
2	dupilumabIBA 01/2022 - 01/2020
2	Proton Pump InhibitorsIBA 12/2018 - 01/2018
1	Interleukin-13IBA 01/2022
1	SteroidsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Budesonide (Pulmicort)FDA LinkGeneric 07/2019
1	AntigensIBA 08/2017
1	Monoclonal AntibodiesIBA 01/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2012
1	Therapeutic UsesIBA 02/2009

6	Therapeutics 01/2022 - 02/2009
1	Patient Readmission 11/2018